Clinical Trials Directory

Trials / Conditions / Childhood Mixed Glioma

Childhood Mixed Glioma

9 registered clinical trials studyying Childhood Mixed Glioma.

StatusTrialSponsorPhase
CompletedVeliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Ponti
NCT01514201
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedSunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or E
NCT01462695
National Cancer Institute (NCI)Phase 2
TerminatedGamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS T
NCT01088763
National Cancer Institute (NCI)Phase 1
CompletedVorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spi
NCT01076530
National Cancer Institute (NCI)Phase 1
CompletedVorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Cent
NCT00994500
National Cancer Institute (NCI)Phase 1
CompletedABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors
NCT00946335
National Cancer Institute (NCI)Phase 1
CompletedLenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors
NCT00100880
National Cancer Institute (NCI)Phase 1
CompletedCilengitide in Treating Children With Refractory Primary Brain Tumors
NCT00063973
National Cancer Institute (NCI)Phase 1
CompletedTemozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors
NCT00052780
National Cancer Institute (NCI)Phase 1